David R Wise
7PUBLICATIONS
68CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Sep 22, 2025
Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patients.Neal D Shore, Christopher M Pieczonka, Sean Heron
|Mar 13, 2025
Cyclin-Dependent Kinase Inhibition in Prostate Cancer: Past, Present, and Future.Matthew Siskin, Minas P Economides, David R Wise
|Dec 19, 2024
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now.Neal Shore, Sarah M Nielsen, Edward D Esplin
|Mar 07, 2024
TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing.Stacy Loeb, Scott W Keith, Heather H Cheng
|Feb 10, 2024
A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC).David R Wise, Russell K Pachynski, Samuel R Denmeade
|Jul 24, 2023
A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer.Justine Habault, Jeffrey A Schneider, Susan Ha
Pageof 2
Frequent Collaborators
2 joint publications
Victor Adorno Febles
2 joint publications
Edward D Esplin
2 joint publications
Neal Shore
2 joint publications
Jiehui Deng
1 joint publications
Kathryn E Hatchell
1 joint publications
Vaibhav G Patel
1 joint publications
Xiaobo Zhong
1 joint publications
Jessica E Hawley
1 joint publications
George Mellgard
1 joint publications
Jones T Nauseef
